Literature DB >> 31054287

Malaria case management in Zambia: A cross-sectional health facility survey.

Matt Worges1, Michael Celone2, Timothy Finn3, Zunda Chisha4, Anna Winters5, Benjamin Winters5, Joseph Keating6, Joshua O Yukich6.   

Abstract

Misdiagnosis of malaria could lead to the overuse of antimalarials resulting in the progression of underlying illness as well as increased risk of mortality. Misdiagnosis is an important consideration as a significant proportion of febrile illnesses in sub-Saharan Africa are attributable to conditions other than malaria. A health facility survey was carried out for a simple random sample of health facilities across 4 provinces of central Zambia in 2014. Twenty-nine facilities with at least 10 outpatients per day were included in the final sample. A modified service provision assessment questionnaire was used for data collection along with several other instruments. Primary outcomes included the quality and accuracy of diagnostic testing for malaria as well as health worker diagnostic and treatment practices. Laboratory technicians displayed 65.5% sensitivity and 86.0% specificity in performing malaria microscopy. Rapid diagnostic test results as reported by health workers were cross-checked by survey staff revealing 99.8% (95% CI: 98.0%-100.0%) concordance. Overall, 69.5% (177/286) (95% CI [58.8%-78.4%]) of patients were reported as febrile of which 37.0% (68/177) (95% CI [21.0%-56.6%]) had a malaria test requested or conducted by their health worker. Appropriate health worker adherence to recommended malaria case management practices (i.e. requesting/conducting malaria tests for febrile patients and providing appropriate antimalarial treatment for test positive cases or forgoing antimalarial treatment for test negative cases) was 30.5% (57/177) (95% CI [17.1%-48.4%]). Presence of fever (aOR = 10.6; 95% CI [3.6-31.2]) and self-reported headache (aOR = 2.2; 95% CI [1.0-4.9]) were significant factors in explaining health worker practices of requesting or performing malaria tests. Routine practice of IQA activities (aOR = 4.8; 95% CI [1.5-15.1]) and self-reported headache (aOR = 3.3; 95% CI [1.1-10.1])) were both significant predictors of antimalarial drug treatment or prescription among malaria untested patients. Prescriber adherence to malaria diagnostic test results in central Zambia is good, but the overall testing rate of febrile patients was low. Additionally, a number of patients observed during this survey were found to have received a clinical diagnosis of malaria without parasitological confirmation and many patients without test results received antimalarial treatment.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adherence; Antimalarial; Case management; Diagnostics; Malaria; Prescribing behavior

Mesh:

Substances:

Year:  2019        PMID: 31054287     DOI: 10.1016/j.actatropica.2019.04.032

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  3 in total

1.  Management of uncomplicated malaria among children under five years at public and private sector facilities in Mali.

Authors:  Seydou Fomba; Diakalia Koné; Bakary Doumbia; Diadier Diallo; Thomas Druetz; Lia Florey; Thomas P Eisele; Erin Eckert; Jules Mihigo; Ruth A Ashton
Journal:  BMC Public Health       Date:  2020-12-09       Impact factor: 3.295

2.  Factors influencing health workers' compliance with outpatient malaria 'test and treat' guidelines during the plateauing performance phase in Kenya, 2014-2016.

Authors:  Beatrice Amboko; Kasia Stepniewska; Beatrice Machini; Philip Bejon; Robert W Snow; Dejan Zurovac
Journal:  Malar J       Date:  2022-03-03       Impact factor: 2.979

3.  Association between the proportion of Plasmodium falciparum and Plasmodium vivax infections detected by passive surveillance and the magnitude of the asymptomatic reservoir in the community: a pooled analysis of paired health facility and community data.

Authors:  Gillian Stresman; Nuno Sepúlveda; Kimberly Fornace; Lynn Grignard; Julia Mwesigwa; Jane Achan; John Miller; Daniel J Bridges; Thomas P Eisele; Jacklin Mosha; Pauline Joy Lorenzo; Maria Lourdes Macalinao; Fe Esperanza Espino; Fitsum Tadesse; Jennifer C Stevenson; Antonio M Quispe; André Siqueira; Marcus Lacerda; Shunmay Yeung; Siv Sovannaroth; Emilie Pothin; Joanna Gallay; Karen E Hamre; Alyssa Young; Jean Frantz Lemoine; Michelle A Chang; Koukeo Phommasone; Mayfong Mayxay; Jordi Landier; Daniel M Parker; Lorenz Von Seidlein; Francois Nosten; Gilles Delmas; Arjen Dondorp; Ewan Cameron; Katherine Battle; Teun Bousema; Peter Gething; Umberto D'Alessandro; Chris Drakeley
Journal:  Lancet Infect Dis       Date:  2020-04-08       Impact factor: 71.421

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.